Clough Capital Partners’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-106,335
| Closed | -$5.61M | – | 161 |
|
|
2018
Q1 | $5.61M | Sell |
106,335
-47,400
| -31% | -$2.5M | 0.54% | 58 |
|
|
2017
Q4 | $10.5M | Buy |
153,735
+70,000
| +84% | +$4.76M | 0.87% | 39 |
|
|
2017
Q3 | $6.9M | Buy |
83,735
+73,200
| +695% | +$6.03M | 0.46% | 57 |
|
|
2017
Q2 | $986K | Sell |
10,535
-5,365
| -34% | -$502K | 0.07% | 99 |
|
|
2017
Q1 | $1.01M | Buy |
15,900
+100
| +0.6% | +$6.37K | 0.06% | 104 |
|
|
2016
Q4 | $702K | Sell |
15,800
-11,700
| -43% | -$520K | 0.05% | 132 |
|
|
2016
Q3 | $991K | Buy |
+27,500
| New | +$991K | 0.05% | 135 |
|